Compare BioNano Genomics Inc (BNGO) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs LTC Properties Inc — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.20M), while LTC Properties Inc trades at $40.29 (market cap $2.05B). The key difference: LTC Properties Inc is far larger — about 155.3× BioNano Genomics Inc's market cap, and LTC Properties Inc pays a 5.7% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | LTC | |
|---|---|---|
Market Cap | $13.20M | $2.05B |
Sector | Health | Real Estate |
52-Week High | $4.92 | $40.36 |
52-Week Low | $1.09 | $33.98 |
Enterprise Value | $15.81M | $2.90B |
Dividend Yield | — | 5.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
LTC Properties (LTC) trades at $39.67, up 2.08% today, with a bullish technical signal from moving averages and a P/E of 15.56. Revenue grew to $263M in 2025, with a net income margin of 39.09%, though recent quarters saw earnings misses. The company is expanding its SHOP portfolio, with acquisitions like the $73M purchase in July 2026, and maintains a monthly dividend of $0.19 per share.
Outlook is mixed: strong fundamentals and demographic trends support growth, but earnings volatility and high debt pose risks. Analysts are cautious, with 59% holding neutral ratings. Key catalysts include SHOP transition success, while risks involve interest rate sensitivity and execution challenges in acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
